ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

CARLOS RODRIGUEZ FIERRO M.D.

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,070Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 300

$1.27M Total Retail Price of All Prescriptions

Rank: 6 out of 300

1,422 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
32% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 16,369 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 4%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $81 among peers.

Prescriptions per Patient

13 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
METOPROLOL SUCCINATE 1,737 1,474 10 1 6
AMLODIPINE BESYLATE 1,048 916 2 2
ATORVASTATIN CALCIUM 960 801 3 14
CARVEDILOL 911 768 4 12
FUROSEMIDE 822 706 5 3
CLOPIDOGREL 696 592 6 18
CRESTOR 584 507 7 26
PRAVASTATIN SODIUM 569 492 8 15
HYDROCHLOROTHIAZIDE 568 496 9 20
SIMVASTATIN 533 461 10 5
LISINOPRIL 496 433 11 4
PLAVIX 478 410 12 24
POTASSIUM CHLORIDE 441 372 13 22
RAMIPRIL 428 346 14 63
WARFARIN SODIUM 360 284 15 10
ISOSORBIDE MONONITRATE ER 348 322 16 32
HYDRALAZINE HCL 339 299 17 56
DIGOXIN 322 281 18 39
LOSARTAN POTASSIUM 301 258 19 29
BENAZEPRIL HCL 300 251 20 73
DIOVAN 296 257 21 46
ATENOLOL 274 242 22 31
PRADAXA 251 229 23 108
METOPROLOL TARTRATE 247 218 24 13
BYSTOLIC 226 167 25 59
NITROGLYCERIN PATCH 213 174 26 258
FENOFIBRATE 203 177 27 98
DIOVAN HCT 195 171 28 94
CLONIDINE HCL 157 128 29 50
AMLODIPINE BESYLATE-BENAZEPRIL 156 128 30 52
LOVASTATIN 152 140 31 68
SPIRONOLACTONE 152 138 31 92
NITROSTAT 146 116 33 157
VERAPAMIL ER 143 109 34 113
AMIODARONE HCL 140 108 35 96
NIASPAN 133 119 36 183
COUMADIN 122 100 37 234
LOVAZA 121 94 38 129
VYTORIN 121 103 38 154
LIPITOR 114 102 40 115
LOSARTAN-HYDROCHLOROTHIAZIDE 111 104 41 97
TRICOR 110 99 42 161
LISINOPRIL-HYDROCHLOROTHIAZIDE 99 86 43 64
RANEXA 93 79 44 124
DILTIAZEM 24HR ER 83 72 45 173
DIPYRIDAMOLE 80 75 R 46 371
BENICAR HCT 80 56 46 316
QUINAPRIL HCL 75 74 48 128
ZETIA 72 53 49 109
EFFIENT 64 52 50 221
XARELTO 64 53 50 325
VALSARTAN-HYDROCHLOROTHIAZIDE 62 53 52 400
TRIAMTERENE-HCTZ 61 42 53 118
DILTIAZEM ER 60 60 54 198
METOLAZONE 60 46 54 295
ENALAPRIL MALEATE 57 56 56 86
VERAPAMIL HCL 54 51 57 428
BENICAR 54 48 57 191
KLOR-CON 10 54 53 57 428
KLOR-CON M20 52 29 60 89
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 20, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.